ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 10 filers reported holding ESSA PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $779,000 | -88.2% | 1,416,230 | -33.2% | 0.04% | -83.5% |
| Q1 2017 | $6,619,000 | +42.5% | 2,121,601 | 0.0% | 0.26% | +33.5% |
| Q4 2016 | $4,646,000 | -20.4% | 2,121,601 | 0.0% | 0.19% | -29.5% |
| Q3 2016 | $5,834,000 | -8.3% | 2,121,601 | -1.6% | 0.27% | +8.4% |
| Q2 2016 | $6,364,000 | -24.3% | 2,157,151 | -16.6% | 0.25% | -30.2% |
| Q1 2016 | $8,408,000 | -1.1% | 2,587,215 | +39.2% | 0.36% | +4.1% |
| Q4 2015 | $8,499,000 | -26.6% | 1,859,282 | 0.0% | 0.34% | -23.2% |
| Q3 2015 | $11,580,000 | – | 1,859,282 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,084,848 | $4,122,000 | 3.04% |